Peripheral Nerve Allografts Using Localized Hydrogel Immunosuppression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for peripheral nerve repair, such as conduits and processed allografts, fail to match the regeneration associated with sensory autografts, and autografts suffer from size mismatch and immunosuppression risks, while allografts face systemic immunosuppression complications.
Innovation Solution
Localized immunosuppression of peripheral nerve allografts using hydrogel materials and polymeric nanoparticles to deliver immunosuppressive agents, Tregs antibodies, and mesenchymal stromal cells, minimizing systemic immunosuppression risks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If allografts are used for peripheral nerve repair, then the limitations of autografts (supply, size mismatch) are overcome, but systemic immunosuppression risks (infections, renal damage, lymphoproliferative disorders) increase
Solution Approach 1:
The invention divides the immunosuppression approach from systemic to localized. Immunosuppressive agents are delivered locally to the allograft site through conduits or direct injection, rather than systemically. This segmentation allows immunosuppression to be confined to the specific area needing it, reducing overall exposure and associated risks while maintaining graft acceptance.
Solution Approach 2:
The invention introduces local immunosuppressive agents as intermediaries between the host immune system and the allograft. These agents (such as corticosteroids, calcineurin inhibitors, or anti-inflammatory cytokines) mediate the interaction by locally suppressing immune rejection at the graft site without requiring systemic immunosuppression, thus protecting the graft while minimizing harmful systemic effects.
2Reliability
If mixed PN autografts are used, then superior nerve regeneration is achieved, but the limited supply of correctly sized nerves causes size mismatch and neuroma formation
Solution Approach 1:
The invention uses allografts as copies of the required nerve structure, rather than relying on the patient's own autografts. Allografts can be obtained in various sizes and configurations to match the specific defect, providing the structural template needed for regeneration without the limitations of autograft availability. The local immunosuppression ensures these allograft copies are accepted by the host system.
3Reliability
If sensory autografts are used as clinical standard, then regeneration is achieved, but secondary surgery with significant morbidity is required
Solution Approach 1:
The invention introduces local immunosuppressive agents as intermediaries that enable allograft acceptance without requiring sensory autografts. This eliminates the need for secondary harvesting surgery while maintaining regeneration capability, as the local immunosuppression mediates between the host immune system and the allograft, preventing rejection without systemic side effects.
Data Source
AI summary
Embodiments described herein relate to restorative solutions for segmental peripheral nerve (PN) defects using allografted PNs for stimulating PN repair. More specifically, embodiments described herein provide for localized immunosuppression (LIS) surrounding PN allografts as an alternative to systemically suppressing a patient's entire immune system. Methods include localized release of immunosuppressive (ISV) agents are contemplated in one embodiment. Methods also include localized application of immunosuppressive (ISV) regulatory T-cells (Tregs) and/or mesenchymal stomal cells in other embodiments. Hydrogel carrier materials are also described herein.